The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Respiratory Disease Testing-Global Market Insights and Sales Trends 2024
Synopsis
Respiratory Disease Testing are clinical assessment equipment of many respiratory diseases
The global Respiratory Disease Testing market size is expected to reach US$ 3287.1 million by 2029, growing at a CAGR of 1.9% from 2023 to 2029. The market is mainly driven by the significant applications of Respiratory Disease Testing in various end use industries. The expanding demands from the Hospitals, Physician Clinics, Clinical Laboratories and Others, are propelling Respiratory Disease Testing market. Imaging Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Respiratory Measurement segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Respiratory Disease Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Respiratory Disease Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Respiratory Disease Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Respiratory Disease Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Respiratory Disease Testing covered in this report include Fischer & Paykel, Medtronic, MGC Diagnostics Corporation, CAREstream Medical Ltd., Becton Dickinson (Carefusion Corporation), Koninklijke Philips N.V. (Respironics) and ResMed Company, etc.
The global Respiratory Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Fischer & Paykel
Medtronic
MGC Diagnostics Corporation
CAREstream Medical Ltd.
Becton Dickinson (Carefusion Corporation)
Koninklijke Philips N.V. (Respironics)
ResMed Company
Global Respiratory Disease Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Respiratory Disease Testing market, Segment by Type:
Imaging Test
Respiratory Measurement
Blood Gas Test
Other
Global Respiratory Disease Testing market, by Application
Hospitals
Physician Clinics
Clinical Laboratories
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Respiratory Disease Testing manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Respiratory Disease Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Respiratory Disease Testing are clinical assessment equipment of many respiratory diseases
The global Respiratory Disease Testing market size is expected to reach US$ 3287.1 million by 2029, growing at a CAGR of 1.9% from 2023 to 2029. The market is mainly driven by the significant applications of Respiratory Disease Testing in various end use industries. The expanding demands from the Hospitals, Physician Clinics, Clinical Laboratories and Others, are propelling Respiratory Disease Testing market. Imaging Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Respiratory Measurement segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Respiratory Disease Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Respiratory Disease Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Respiratory Disease Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Respiratory Disease Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Respiratory Disease Testing covered in this report include Fischer & Paykel, Medtronic, MGC Diagnostics Corporation, CAREstream Medical Ltd., Becton Dickinson (Carefusion Corporation), Koninklijke Philips N.V. (Respironics) and ResMed Company, etc.
The global Respiratory Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Fischer & Paykel
Medtronic
MGC Diagnostics Corporation
CAREstream Medical Ltd.
Becton Dickinson (Carefusion Corporation)
Koninklijke Philips N.V. (Respironics)
ResMed Company
Global Respiratory Disease Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Respiratory Disease Testing market, Segment by Type:
Imaging Test
Respiratory Measurement
Blood Gas Test
Other
Global Respiratory Disease Testing market, by Application
Hospitals
Physician Clinics
Clinical Laboratories
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Respiratory Disease Testing manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Respiratory Disease Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Respiratory Disease Testing Market Overview
1.1 Respiratory Disease Testing Product Overview
1.2 Respiratory Disease Testing Market Segment by Type
1.2.1 Imaging Test
1.2.2 Respiratory Measurement
1.2.3 Blood Gas Test
1.2.4 Other
1.3 Global Respiratory Disease Testing Market Size by Type
1.3.1 Global Respiratory Disease Testing Market Size Overview by Type (2018-2029)
1.3.2 Global Respiratory Disease Testing Historic Market Size Review by Type (2018-2023)
1.3.3 Global Respiratory Disease Testing Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Respiratory Disease Testing Sales Breakdown by Type (2018-2023)
1.4.2 Europe Respiratory Disease Testing Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Respiratory Disease Testing Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Respiratory Disease Testing Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Respiratory Disease Testing Sales Breakdown by Type (2018-2023)
2 Global Respiratory Disease Testing Market Competition by Company
2.1 Global Top Players by Respiratory Disease Testing Sales (2018-2023)
2.2 Global Top Players by Respiratory Disease Testing Revenue (2018-2023)
2.3 Global Top Players by Respiratory Disease Testing Price (2018-2023)
2.4 Global Top Manufacturers Respiratory Disease Testing Manufacturing Base Distribution, Sales Area, Product Type
2.5 Respiratory Disease Testing Market Competitive Situation and Trends
2.5.1 Respiratory Disease Testing Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Respiratory Disease Testing Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Respiratory Disease Testing as of 2022)
2.7 Date of Key Manufacturers Enter into Respiratory Disease Testing Market
2.8 Key Manufacturers Respiratory Disease Testing Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Respiratory Disease Testing Status and Outlook by Region
3.1 Global Respiratory Disease Testing Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Respiratory Disease Testing Historic Market Size by Region
3.2.1 Global Respiratory Disease Testing Sales in Volume by Region (2018-2023)
3.2.2 Global Respiratory Disease Testing Sales in Value by Region (2018-2023)
3.2.3 Global Respiratory Disease Testing Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Respiratory Disease Testing Forecasted Market Size by Region
3.3.1 Global Respiratory Disease Testing Sales in Volume by Region (2024-2029)
3.3.2 Global Respiratory Disease Testing Sales in Value by Region (2024-2029)
3.3.3 Global Respiratory Disease Testing Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Respiratory Disease Testing by Application
4.1 Respiratory Disease Testing Market Segment by Application
4.1.1 Hospitals
4.1.2 Physician Clinics
4.1.3 Clinical Laboratories
4.1.4 Others
4.2 Global Respiratory Disease Testing Market Size by Application
4.2.1 Global Respiratory Disease Testing Market Size Overview by Application (2018-2029)
4.2.2 Global Respiratory Disease Testing Historic Market Size Review by Application (2018-2023)
4.2.3 Global Respiratory Disease Testing Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Respiratory Disease Testing Sales Breakdown by Application (2018-2023)
4.3.2 Europe Respiratory Disease Testing Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Respiratory Disease Testing Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Respiratory Disease Testing Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Respiratory Disease Testing Sales Breakdown by Application (2018-2023)
5 North America Respiratory Disease Testing by Country
5.1 North America Respiratory Disease Testing Historic Market Size by Country
5.1.1 North America Respiratory Disease Testing Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Respiratory Disease Testing Sales in Volume by Country (2018-2023)
5.1.3 North America Respiratory Disease Testing Sales in Value by Country (2018-2023)
5.2 North America Respiratory Disease Testing Forecasted Market Size by Country
5.2.1 North America Respiratory Disease Testing Sales in Volume by Country (2024-2029)
5.2.2 North America Respiratory Disease Testing Sales in Value by Country (2024-2029)
6 Europe Respiratory Disease Testing by Country
6.1 Europe Respiratory Disease Testing Historic Market Size by Country
6.1.1 Europe Respiratory Disease Testing Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Respiratory Disease Testing Sales in Volume by Country (2018-2023)
6.1.3 Europe Respiratory Disease Testing Sales in Value by Country (2018-2023)
6.2 Europe Respiratory Disease Testing Forecasted Market Size by Country
6.2.1 Europe Respiratory Disease Testing Sales in Volume by Country (2024-2029)
6.2.2 Europe Respiratory Disease Testing Sales in Value by Country (2024-2029)
7 Asia-Pacific Respiratory Disease Testing by Region
7.1 Asia-Pacific Respiratory Disease Testing Historic Market Size by Region
7.1.1 Asia-Pacific Respiratory Disease Testing Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Respiratory Disease Testing Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Respiratory Disease Testing Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Respiratory Disease Testing Forecasted Market Size by Region
7.2.1 Asia-Pacific Respiratory Disease Testing Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Respiratory Disease Testing Sales in Value by Region (2024-2029)
8 Latin America Respiratory Disease Testing by Country
8.1 Latin America Respiratory Disease Testing Historic Market Size by Country
8.1.1 Latin America Respiratory Disease Testing Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Respiratory Disease Testing Sales in Volume by Country (2018-2023)
8.1.3 Latin America Respiratory Disease Testing Sales in Value by Country (2018-2023)
8.2 Latin America Respiratory Disease Testing Forecasted Market Size by Country
8.2.1 Latin America Respiratory Disease Testing Sales in Volume by Country (2024-2029)
8.2.2 Latin America Respiratory Disease Testing Sales in Value by Country (2024-2029)
9 Middle East and Africa Respiratory Disease Testing by Country
9.1 Middle East and Africa Respiratory Disease Testing Historic Market Size by Country
9.1.1 Middle East and Africa Respiratory Disease Testing Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Respiratory Disease Testing Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Respiratory Disease Testing Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Respiratory Disease Testing Forecasted Market Size by Country
9.2.1 Middle East and Africa Respiratory Disease Testing Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Respiratory Disease Testing Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Fischer & Paykel
10.1.1 Fischer & Paykel Company Information
10.1.2 Fischer & Paykel Introduction and Business Overview
10.1.3 Fischer & Paykel Respiratory Disease Testing Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Fischer & Paykel Respiratory Disease Testing Products Offered
10.1.5 Fischer & Paykel Recent Development
10.2 Medtronic
10.2.1 Medtronic Company Information
10.2.2 Medtronic Introduction and Business Overview
10.2.3 Medtronic Respiratory Disease Testing Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Medtronic Respiratory Disease Testing Products Offered
10.2.5 Medtronic Recent Development
10.3 MGC Diagnostics Corporation
10.3.1 MGC Diagnostics Corporation Company Information
10.3.2 MGC Diagnostics Corporation Introduction and Business Overview
10.3.3 MGC Diagnostics Corporation Respiratory Disease Testing Sales, Revenue and Gross Margin (2018-2023)
10.3.4 MGC Diagnostics Corporation Respiratory Disease Testing Products Offered
10.3.5 MGC Diagnostics Corporation Recent Development
10.4 CAREstream Medical Ltd.
10.4.1 CAREstream Medical Ltd. Company Information
10.4.2 CAREstream Medical Ltd. Introduction and Business Overview
10.4.3 CAREstream Medical Ltd. Respiratory Disease Testing Sales, Revenue and Gross Margin (2018-2023)
10.4.4 CAREstream Medical Ltd. Respiratory Disease Testing Products Offered
10.4.5 CAREstream Medical Ltd. Recent Development
10.5 Becton Dickinson (Carefusion Corporation)
10.5.1 Becton Dickinson (Carefusion Corporation) Company Information
10.5.2 Becton Dickinson (Carefusion Corporation) Introduction and Business Overview
10.5.3 Becton Dickinson (Carefusion Corporation) Respiratory Disease Testing Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Becton Dickinson (Carefusion Corporation) Respiratory Disease Testing Products Offered
10.5.5 Becton Dickinson (Carefusion Corporation) Recent Development
10.6 Koninklijke Philips N.V. (Respironics)
10.6.1 Koninklijke Philips N.V. (Respironics) Company Information
10.6.2 Koninklijke Philips N.V. (Respironics) Introduction and Business Overview
10.6.3 Koninklijke Philips N.V. (Respironics) Respiratory Disease Testing Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Koninklijke Philips N.V. (Respironics) Respiratory Disease Testing Products Offered
10.6.5 Koninklijke Philips N.V. (Respironics) Recent Development
10.7 ResMed Company
10.7.1 ResMed Company Company Information
10.7.2 ResMed Company Introduction and Business Overview
10.7.3 ResMed Company Respiratory Disease Testing Sales, Revenue and Gross Margin (2018-2023)
10.7.4 ResMed Company Respiratory Disease Testing Products Offered
10.7.5 ResMed Company Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Respiratory Disease Testing Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Respiratory Disease Testing Industrial Chain Analysis
11.4 Respiratory Disease Testing Market Dynamics
11.4.1 Respiratory Disease Testing Industry Trends
11.4.2 Respiratory Disease Testing Market Drivers
11.4.3 Respiratory Disease Testing Market Challenges
11.4.4 Respiratory Disease Testing Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Respiratory Disease Testing Distributors
12.3 Respiratory Disease Testing Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
